Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review
Background: Metabolomic based approaches are essential tools in the discovery of unique biomarkers for infectious diseases via high-throughput global assessment of metabolites and metabolite pathway dysregulation. This in-turn allows the development of diagnostic tools and provision of therapeutics....
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | research article |
| Language: | English |
| Published: |
Frontiers Media
2023
|
| Subjects: | |
| Online Access: | https://cris.library.msu.ac.zw//handle/11408/5606 https://doi.org/10.3389/fitd.2023.1108317 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1779905250184921088 |
|---|---|
| author | Herald Midzi Arthur Vengesai Victor Muleya Maritha Kasambala Tariro Lavender Mduluza-Jokonya Isaac Chipako Clayton Edmore Siamayuwa Francisca Mutapi Thajasvarie Naicker Takafira Mduluza |
| author2 | Department of Biochemistry and Biotechnology, University of Zimbabwe, Harare, Zimbabwe; Doris Duke Medical Research Institute, College of Health Sciences, Optics & Imaging, University of KwaZulu-Natal, KwaZulu-Natal, Durban, South Africa |
| author_facet | Department of Biochemistry and Biotechnology, University of Zimbabwe, Harare, Zimbabwe; Doris Duke Medical Research Institute, College of Health Sciences, Optics & Imaging, University of KwaZulu-Natal, KwaZulu-Natal, Durban, South Africa Herald Midzi Arthur Vengesai Victor Muleya Maritha Kasambala Tariro Lavender Mduluza-Jokonya Isaac Chipako Clayton Edmore Siamayuwa Francisca Mutapi Thajasvarie Naicker Takafira Mduluza |
| author_sort | Herald Midzi |
| collection | DSpace |
| description | Background: Metabolomic based approaches are essential tools in the discovery of unique biomarkers for infectious diseases via high-throughput global assessment of metabolites and metabolite pathway dysregulation. This in-turn allows the development of diagnostic tools and provision of therapeutics. In this review, we aimed to give an overview of metabolite biomarkers and metabolic pathway alterations during Schistosoma haematobium and Schistosoma mansoni infections.
Methods: We conducted the review by systematically searching electronic databases and grey literature to identify relevant metabolomics studies on schistosomiasis. Arksey and O’Malley methodology for conducting systematic scoping reviews was applied. A narrative summary of results was conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for scoping review guidelines.
Results: Twelve articles included in the review identified 127 metabolites, whose concentrations were considerably altered during S. mansoni and S. haematobium infections. The metabolites were assigned to metabolic pathways involved in energy (34.6%), gut microbial (11.0%), amino acid (25.2%), nucleic acids (6.3%), immune proteins (8.7%) hormones (2.4%) and structural proteins/lipids (11.8%). Energy related metabolic pathways were the most affected during schistosome infections with metabolites such as succinate, citrate, aconitate and fumarate of the tricarbocylic acid cycle being significantly altered in organ, serum and plasma samples. Amino acid metabolism was also impacted during schistosome infections as phenylacetylglycine, alanine, taurine, 2-oxoisocaproate and 2-oxoisovalerate emerged as potent biomarkers. Elevated structural proteins such as actin, collagen and keratin concentrations were identified as biomarkers of liver fibrosis, a common pathological feature in chronic schistosomiasis infections. Hippurate was a major metabolite biomarker in the gut microbial related pathway.
Conclusions: The analysis of the literature revealed that energy related metabolic pathways are considerably altered during S. mansoni and S. haematobium infections. Therefore, their metabolites may provide biomarkers for diagnosis and prognosis in addition to providing therapeutics for parasitic infections. This scoping review has identified a need to replicate more schistosomiasis metabolomic studies in humans to complement animal-model based studies. |
| format | research article |
| id | ir-11408-5606 |
| institution | My University |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media |
| record_format | dspace |
| spelling | ir-11408-56062023-05-04T12:18:57Z Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review Herald Midzi Arthur Vengesai Victor Muleya Maritha Kasambala Tariro Lavender Mduluza-Jokonya Isaac Chipako Clayton Edmore Siamayuwa Francisca Mutapi Thajasvarie Naicker Takafira Mduluza Department of Biochemistry and Biotechnology, University of Zimbabwe, Harare, Zimbabwe; Doris Duke Medical Research Institute, College of Health Sciences, Optics & Imaging, University of KwaZulu-Natal, KwaZulu-Natal, Durban, South Africa Faculty of Medicine and Health Sciences, Department of Biochemistry, Midlands State University, Gweru, Zimbabwe Faculty of Medicine and Health Sciences, Department of Biochemistry, Midlands State University, Gweru, Zimbabwe Department of Biological Sciences and Ecology, University of Zimbabwe, Harare, Zimbabwe Doris Duke Medical Research Institute, College of Health Sciences, Optics & Imaging, University of KwaZulu-Natal, KwaZulu-Natal, Durban, South Africa; Faculty of Medicine and Health Science, University of Zimbabwe, Harare, Zimbabwe Pharmacology Department Aravas Pharmaceuticals Pvt LTD, Prospect Industrial Area, Harare, Zimbabwe Department of Biochemistry and Biotechnology, University of Zimbabwe, Harare, Zimbabwe Ashworth Laboratories, Institute for Immunology and Infection Research and Centre for Immunity, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, Scotland Doris Duke Medical Research Institute, College of Health Sciences, Optics & Imaging, University of KwaZulu-Natal, KwaZulu-Natal, Durban, South Africa Department of Biochemistry and Biotechnology, University of Zimbabwe, Harare, Zimbabwe Metabolites Biomarkers S. haematobium S. mansoni Schistosomiasis Background: Metabolomic based approaches are essential tools in the discovery of unique biomarkers for infectious diseases via high-throughput global assessment of metabolites and metabolite pathway dysregulation. This in-turn allows the development of diagnostic tools and provision of therapeutics. In this review, we aimed to give an overview of metabolite biomarkers and metabolic pathway alterations during Schistosoma haematobium and Schistosoma mansoni infections. Methods: We conducted the review by systematically searching electronic databases and grey literature to identify relevant metabolomics studies on schistosomiasis. Arksey and O’Malley methodology for conducting systematic scoping reviews was applied. A narrative summary of results was conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for scoping review guidelines. Results: Twelve articles included in the review identified 127 metabolites, whose concentrations were considerably altered during S. mansoni and S. haematobium infections. The metabolites were assigned to metabolic pathways involved in energy (34.6%), gut microbial (11.0%), amino acid (25.2%), nucleic acids (6.3%), immune proteins (8.7%) hormones (2.4%) and structural proteins/lipids (11.8%). Energy related metabolic pathways were the most affected during schistosome infections with metabolites such as succinate, citrate, aconitate and fumarate of the tricarbocylic acid cycle being significantly altered in organ, serum and plasma samples. Amino acid metabolism was also impacted during schistosome infections as phenylacetylglycine, alanine, taurine, 2-oxoisocaproate and 2-oxoisovalerate emerged as potent biomarkers. Elevated structural proteins such as actin, collagen and keratin concentrations were identified as biomarkers of liver fibrosis, a common pathological feature in chronic schistosomiasis infections. Hippurate was a major metabolite biomarker in the gut microbial related pathway. Conclusions: The analysis of the literature revealed that energy related metabolic pathways are considerably altered during S. mansoni and S. haematobium infections. Therefore, their metabolites may provide biomarkers for diagnosis and prognosis in addition to providing therapeutics for parasitic infections. This scoping review has identified a need to replicate more schistosomiasis metabolomic studies in humans to complement animal-model based studies. 4 2023-05-04T12:18:56Z 2023-05-04T12:18:56Z 2023-01-31 research article https://cris.library.msu.ac.zw//handle/11408/5606 https://doi.org/10.3389/fitd.2023.1108317 en #PLACEHOLDER_PARENT_METADATA_VALUE# The proposed study ideation emanated from a study supported by the Royal Society Grants Frontiers in Tropical Diseases 2673-7515 ICA_R1_201399 open Frontiers Media |
| spellingShingle | Metabolites Biomarkers S. haematobium S. mansoni Schistosomiasis Herald Midzi Arthur Vengesai Victor Muleya Maritha Kasambala Tariro Lavender Mduluza-Jokonya Isaac Chipako Clayton Edmore Siamayuwa Francisca Mutapi Thajasvarie Naicker Takafira Mduluza Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review |
| title | Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review |
| title_full | Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review |
| title_fullStr | Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review |
| title_full_unstemmed | Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review |
| title_short | Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review |
| title_sort | metabolomics for biomarker discovery in schistosomiasis: a systematic scoping review |
| topic | Metabolites Biomarkers S. haematobium S. mansoni Schistosomiasis |
| url | https://cris.library.msu.ac.zw//handle/11408/5606 https://doi.org/10.3389/fitd.2023.1108317 |
| work_keys_str_mv | AT heraldmidzi metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview AT arthurvengesai metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview AT victormuleya metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview AT marithakasambala metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview AT tarirolavendermduluzajokonya metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview AT isaacchipako metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview AT claytonedmoresiamayuwa metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview AT franciscamutapi metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview AT thajasvarienaicker metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview AT takafiramduluza metabolomicsforbiomarkerdiscoveryinschistosomiasisasystematicscopingreview |